In this double-blind , double-dummy trial , patients with symptomatic angina pectoris and positive exercise tolerance test were randomized into the Iva [ 5 or 7.5 mg bis in die ( BID ) ] or Aten group ( 12.5 or 25mg BID ) according to computer-generated random numbers for 12weeks .